Bollard Group LLC Shockwave Medical, Inc. Transaction History

Bollard Group LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$160.99 - $215.69 $4,024 - $5,392	25 Added 1.2%	2,100 $400,000
Q3 2023 Nov 14, 2023	BUY	$194.33 - $283.97 $72,873 - $106,488	375 Added 22.06%	2,075 $413,000
Q4 2022 Feb 10, 2023	BUY	$204.38 - $296.82 $20,438 - $29,682	100 Added 6.25%	1,700 $350,000
Q3 2022 Nov 09, 2022	SELL	$195.21 - $310.53 $48,802 - $77,632	-250 Reduced 13.51%	1,600 $445,000
Q2 2022 Aug 12, 2022	BUY	$115.91 - $214.48 $40,568 - $75,068	350 Added 23.33%	1,850 $354,000
Q1 2022 May 12, 2022	BUY	$127.96 - $207.36 $25,592 - $41,472	200 Added 15.38%	1,500 $311,000
Q4 2021 Feb 11, 2022	BUY	$165.13 - $241.83 $49,539 - $72,549	300 Added 30.0%	1,300 $232,000
Q3 2021 Nov 12, 2021	BUY	$163.99 - $235.57 $65,268 - $93,756	398 Added 66.11%	1,000 $206,000
Q2 2021 Aug 12, 2021	BUY	$131.45 - $201.49 $46,138 - $70,722	351 Added 139.84%	602 $114,000
Q1 2021 May 11, 2021	BUY	$92.73 - $142.05 $23,182 - $35,512	250 Added 25000.0%	251 $33,000
Q4 2019 Feb 10, 2020	SELL	$29.4 - $44.98 $5,850 - $8,951	-199 Reduced 99.5%	1 $0
Q1 2019 May 10, 2019	BUY	$29.41 - $38.1 $5,882 - $7,620	200 New	200 $7,000

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Bollard Group LLC, based on Form 13F filings with the SEC.

Stay updated on Bollard Group LLC with notifications on news.